Expert Rev Pharmacoecon Outcomes Res
October 2022
Introduction: Economic evaluations typically focus solely on patient-specific costs with economic spillovers to informal caregivers less frequently evaluated. This may systematically underestimate the burden resulting from disease.
Areas Covered: Cost-of-illness (COI) analyses that identified costs borne to caregiver(s) were identified using PubMed and Embase.